Pharmaceutical Composition
A pharmaceutical composition comprising an active pharmaceutical composition contained in a water-soluble carrier which is selected from the group comprising polyacrilamide/polyacrylate co-polymer, polyacrylic acid, polyacrylate and mixtures of these is provided.
1 . A pharmaceutical composition comprising an active pharmaceutical composition contained in a water-soluble carrier which is selected from the group consisting of polyacrilamide/polyacrylate co-polymer, polyacrylic acid, polyacrylate and mixtures of these.
2 . A pharmaceutical composition as claimed in claim 1 in which the polyacrylate is a sodium cross-linked polyacrylate.
3 . A pharmaceutical composition as claimed in claim 1 or claim 2 in which the polyacrylate is present in the range 10 to 20% m/m.
4 . A pharmaceutical composition as claimed in any one of the preceding claims in which the polyacrilamide/polyacrylate co-polymer is present in the range 15 to 50% m/m.
5 . A pharmaceutical composition as claimed in any one of the preceding claims in which the polyacrylic acid is present in the range 2 to 20% m/m.
6 . A pharmaceutical composition as claimed in any one of the preceding claims in which the active pharmaceutical composition is a pesticide.
7 . A pharmaceutical composition as claimed in claim 6 in which the pesticide is a herbicide.
8 . A pharmaceutical composition as claimed in claim 6 in which the pesticide is suitable for controlling or eradicating mammalian pests.
9 . A pharmaceutical composition as claimed in claim 8 in which the pesticide is suitable for controlling or eradicating ectoparasites.
10 . A pharmaceutical composition as claimed in claim 8 in which the pesticide is an acaricide.
11 . A pharmaceutical composition as claimed in claim 10 in which the acaricide belongs to the amidine group of pesticides.
12 . A pharmaceutical composition as claimed in claim 11 in which the pesticide is AMITRAZ.
13 . A pharmaceutical composition as claimed in claim 12 in which the AMITRAZ is present in the range 30 to 65% m/m.
14 . A pharmaceutical composition as claimed in any one of the preceding claims which further includes any one or more of at least one dispersant, at least one disintegrant, at least one surfactant and at least one filler.
15 . A pharmaceutical composition as claimed in claim 14 in which the dispersant is a sodium salt of the condensation product of naphalene sulphuric acid.
16 . A pharmaceutical composition as claimed in claim 15 in which the dispersant is WETTOL D2.
17 . A pharmaceutical composition as claimed in any one of claims 14 to 16 in which the dispersant is present in the range 1 to 2% m/m.
18 . A pharmaceutical composition as claimed in any one of claims 14 to 17 in which the surfactant is a non-ionic surfactant belonging to the nonylphenol ethoxylate group.
19 . A pharmaceutical composition as claimed in claim 18 in which the surfactant is ARKOPAL N090.
20 . A pharmaceutical composition as claimed in any one of claims 14 to 19 in which the surfactant is present in the range 2 to 4% m/m.
21 . A pharmaceutical composition as claimed in any one of claims 14 to 20 in which the disintegrant is sodium starch glycolate.
22 . A pharmaceutical composition as claimed in claim 21 in which the sodium starch glycolate is present in the range 0 to 15% m/m.
23 . A pharmaceutical composition as claimed in any one of claims 14 to claim 22 which includes calcium carbonate present in the range 5 to 20% m/m.